Meet S. Leigh Verbois, Ph.D., Acting Assistant Commissioner for International Programs
Leigh Verbois, Ph.D. is currently Acting Assistant Commissioner for International Programs with the U.S. Food and Drug Administration (FDA) where she develops coordinated strategies to protect and promote public health through international collaboration. Previously, she served in Beijing as FDA Country Director for the People’s Republic of China where she served as the overall lead for FDA’s efforts in China. Before posting to China she oversaw FDA regulatory engagement with countries in the Asia-Pacific (excepting China and India), Middle East, Africa and Canada as Director of the Office of Regional and Country Affairs within OIP. Dr. Verbois began her FDA career as a reviewer in the Center for Drug Evaluation’s Office of New Drugs. Subsequently, she developed and directed strategies, activities, and policies to reduce threats to the global drug supply chain through increased transparency and accountability, effective enforcement, and promotion of proactive industry vigilance and voluntary compliance in CDER’s Office of Compliance. Dr. Verbois previously served in the Office of Global Regulatory Operations and Policy as Senior Advisor, Acting Assistant Commissioner for Compliance Policy in the Office of Regulatory Affairs and Acting Deputy Director of FDA’s China Office. In these capacities she guided multidisciplinary teams to facilitate strategic decisions, develop policy that is data driven and risk-based and managed resources. Dr. Verbois received her undergraduate degree from Tulane University, her Ph.D. in Pharmaceutical Sciences from the College of Pharmacy at the University of Kentucky and completed her postdoctoral training at the National Institutes of Health.